Note: These resources are provided as an electronic supplement to an article in the March 2009 issue of NWA World Traveler.
Donald Hensrud, M.D., a Mayo Clinic nutrition and preventive medicine specialist, discusses the scientific evidence behind various vitamin supplements:
Here is a link to a fact sheet from the NIH on vitamin [...]
Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. It also causes blood stream infections and brain infections. According to the Centers for Disease Control, pneumococcal infection is one of the leading causes [...]
Findings from a new study prompt Mayo Clinic researchers to recommend CYP2D6 gene testing for postmenopausal women about to begin tamoxifen therapy. New data confirms that women with an inherited deficiency in the CYP2D6 gene important for the metabolism of tamoxifen have a nearly 4-fold higher risk of early breast cancer recurrence compared to women [...]
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.
Their study, presented at the 31st annual San Antonio Breast Cancer Symposium, finds that, in contrast to the [...]
As described in the February 2009 issue of NWA World Traveler, a Mayo Clinic orthopedic surgeon has discovered a type of wrist injury that can cause debilitating pain.
It doesn’t just affect elite professional athletes like Philadelphia Phillies outfielder Jayson Werth, though. The video below tells the story of an amateur bowler who also had a [...]
Mayo Clinic researchers have found a new medication, pomalidomide, designed to optimize immune functions for patients with myelofibrosis, a serious bone marrow disorder. According to a Mayo Clinic study presented Monday at the 50th Annual Meeting of the American Society of Hematology in San Francisco, pomalidomide is well tolerated in patients with myelofibrosis.
Myelofibrosis is a form [...]
Dr. John Miller presented research at the Radiological Society of North America’s 94th Scientific Assembly and Annual Meeting on Friday, Dec. 5 about Mayo Clinic’s examination of the use of coronary CTA and examination of the criteria that physicians use to decide when the coronary CTA should be ordered.
Coronary CTA is a new test that [...]
A new Mayo Clinic study found that it is generally safe to withdraw anti-seizure medications in children with epilepsy who have achieved seizure-freedom while on the medication. Researchers found that these children were not at high risk of subsequently developing intractable epilepsy.
“The risk of children developing intractable epilepsy after withdrawal of anti-seizure medication was only [...]
A new Mayo Clinic study found that patients with low-grade gliomas survived longest when they underwent aggressive surgeries to successfully remove the entire tumor. If safely removing the entire tumor was not possible, patients survived significantly longer when surgery was followed by radiation therapy.
“This study is exciting because it shows how well glioma patients can [...]
Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a Mayo Clinic study presented today at the 50th Annual Meeting of the American Society of Hematology in San Francisco. In fact, statins may slow the progression of certain types of lymphoma.
The study focused on [...]
|
